Papers - Narita Takuma
-
Subsequent systemic therapy initiation after first-line discontinuation in metastatic renal cell carcinoma: insights from a Japanese real-world cohort.
Sato H, Narita T, Sekine Y, Shinohara M, Kawashima Y, Mori K, Numakura K, Kodama H, Mikami J, Fujita N, Okamoto T, Yamamoto H, Narita S, Sato S, Habuchi T, Ohyama C, Hatakeyama S
ESMO real world data and digital oncology 13 100733 2026.9
-
Real-world trends in anti-androgen prescribing and associated costs for prostate cancer in Japan: a nationwide analysis.
Omizo S, Narita T, Hamaya T, Togashi K, Ogawa I, Tazawa S, Ishimoto K, Sakao M, Mikami J, Fujita N, Okamoto T, Imai A, Yamamoto H, Ohyama C, Hatakeyama S
Japanese journal of clinical oncology 2026.7
-
Association of EVITA with safety in advanced urothelial carcinoma: A multicenter real-world study.
Ishimoto K, Narita T, Sekine Y, Shinohara M, Fujita N, Kawashima Y, Narita S, Kobayashi S, Abe N, Kodama H, Okamoto T, Yamamoto H, Numakura K, Sato S, Habuchi T, Ohyama C, Hatakeyama S
Urologic oncology 44 ( 9 ) 165 - 172 2026.6
-
Real-world Outcomes of Adjuvant Nivolumab in High-risk Bladder and Upper Tract Urothelial Carcinoma after Radical Surgery.
Tazawa S, Shinohara M, Kawashima Y, Sekine Y, Narita S, Kobayashi S, Abe N, Narita T, Fujita N, Mikami J, Okamoto T, Yamamoto H, Numakura K, Sato S, Habuchi T, Ohyama C, Hatakeyama S
European urology open science 88 90 - 98 2026.6
-
Visualizing eligibility gaps between muscle-invasive bladder cancer trials and real-world patients.
Ichiyama T, Narita T, Sekine Y, Shinohara M, Kawashima Y, Kobayashi M, Numakura K, Mikami J, Fujita N, Okamoto T, Yamamoto H, Narita S, Sato S, Habuchi T, Ohyama C, Hatakeyama S
Japanese journal of clinical oncology 2026.5
-
CT-based renal artery caliber change as a potential imaging marker of treatment response in renal cell carcinoma; an exploratory imaging study.
Asanuma H, Okamoto T, Yoshizawa T, Oishi T, Hamaya T, Kodama H, Narita T, Mikami J, Fujita N, Yoneyama T, Yamamoto H, Imai A, Ohyama C, Hatakeyama S
Cancer imaging : the official publication of the International Cancer Imaging Society 26 ( 1 ) 2026.3
-
Overactive Bladder Symptoms as a Predictor of Longitudinal Decline in Grip Strength in Community-Dwelling Men: A 4-Year Longitudinal Study.
Sato H, Okamoto T, Hamaya T, Kodama H, Narita T, Mikami J, Fujita N, Yamamoto H, Imai A, Murashita K, Nakaji S, Hatakeyama S
Lower urinary tract symptoms 18 ( 2 ) e70056 2026.3
-
Immediate Postoperative cfDNA Elevation Predicts Pain After Robot-Assisted Radical Prostatectomy.
Ishii N, Yoneyama T, Minakawa S, Konishi S, Kodama H, Narita T, Mikami J, Fujita N, Okamoto T, Yamamoto H, Imai A, Ohyama C, Hatakeyama S
International journal of urology : official journal of the Japanese Urological Association 33 ( 1 ) e70297 2026.1
-
Integrated Assessment of Percentage α2,3-Linked Sialylated Prostate-specific Antigen and the Prostate Health Index with Magnetic Resonance Imaging for Detection of Clinically Significant Prostate Cancer.
Oishi T, Yoneyama T, Miura Y, Hamaya T, Kodama H, Narita T, Mikami J, Fujita N, Okamoto T, Yamamoto H, Imai A, Ohyama C, Hatakeyama S
European urology open science 83 158 - 165 2026.1
-
TMEM2 is a bona fide hyaluronidase possessing intrinsic catalytic activity.
Narita T, Tobisawa Y, Bobkov A, Jackson M, Ohyama C, Irie F, Yamaguchi Y
The Journal of biological chemistry 299 ( 9 ) 105120 2023.9
-
Trends of incidence and age in adults with testicular germ cell tumors: a two-decade multicenter retrospective study.
Ozaki Y, Narita T, Hatakeyama S, Tanaka T, Togashi K, Hamaya T, Ozaki K, Ishi N, Oishi T, Tokui N, Mikami J, Okamoto T, Yamamoto H, Yoneyama T, Hashimoto Y, Ohyama C
Translational andrology and urology 12 ( 2 ) 161 - 167 2023.2
-
Humoral response after SARS-CoV-2 mRNA vaccination in patients with prostate cancer using steroids.
Ishii N, Hatakeyama S, Yoneyama T, Tanaka R, Narita T, Fujita N, Okamoto T, Yamamoto H, Yoneyama T, Hashimoto Y, Ohyama C
Urologic oncology 40 ( 10 ) 451.e1 - 451.e8 2022.10
-
Single immediate instillation of chemotherapy is associated with decreased recurrence and progression in patients with high-risk non-muscle-invasive bladder cancer who receive adjuvant induction bacillus Calmette-Guérin therapy.
Fujita N, Hatakeyama S, Momota M, Narita T, Tobisawa Y, Yoneyama T, Yamamoto H, Ito H, Yoneyama T, Hashimoto Y, Yoshikawa K, Ohyama C
International journal of urology : official journal of the Japanese Urological Association 29 ( 8 ) 867 - 875 2022.8
-
Effect of active anticancer therapy on serologic response to SARS-CoV-2 BNT162b2 vaccine in patients with urothelial and renal cell carcinoma.
Togashi K, Hatakeyama S, Yoneyama T, Hamaya T, Narita T, Fujita N, Iwamura H, Okamoto T, Yamamoto H, Yoneyama T, Hashimoto Y, Ohyama C
International journal of urology : official journal of the Japanese Urological Association 29 ( 7 ) 733 - 739 2022.7
-
Machine learning diagnosis by immunoglobulin N-glycan signatures for precision diagnosis of urological diseases.
Iwamura H, Mizuno K, Akamatsu S, Hatakeyama S, Tobisawa Y, Narita S, Narita T, Yamashita S, Kawamura S, Sakurai T, Fujita N, Kodama H, Noro D, Kakizaki I, Nakaji S, Itoh K, Tsuchiya N, Ito A, Habuchi T, Ohyama C, Yoneyama T
Cancer science 113 ( 7 ) 2434 - 2445 2022.7
-
Significance of pelvic lymph node dissection during radical prostatectomy in high-risk prostate cancer patients receiving neoadjuvant chemohormonal therapy.
Iwamura H, Hatakeyama S, Narita T, Ozaki Y, Konishi S, Horiguchi H, Kodama H, Kojima Y, Fujita N, Okamoto T, Tobisawa Y, Yoneyama T, Yamamoto H, Yoneyama T, Hashimoto Y, Ohyama C
Scientific reports 12 ( 1 ) 9675 2022.6
-
Management of bladder cancer in older patients.
Hatakeyama S, Narita S, Okita K, Narita T, Iwamura H, Fujita N, Inokuchi J, Matsui Y, Kitamura H, Ohyama C
Japanese journal of clinical oncology 52 ( 3 ) 203 - 213 2022.3
-
Editorial Comment to Comparative oncological outcomes after radical prostatectomy or external beam radiation therapy plus androgen deprivation therapy in men with clinical T3b prostate cancer.
Narita T, Hatakeyama S, Ohyama C
International journal of urology : official journal of the Japanese Urological Association 2022.3
-
Prognostic impact of proton pump inhibitors for immunotherapy in advanced urothelial carcinoma.
Okuyama Y, Hatakeyama S, Numakura K, Narita T, Tanaka T, Miura Y, Sasaki D, Noro D, Tokui N, Okamoto T, Yamamoto H, Narita S, Yoneyama T, Hashimoto Y, Habuchi T, Ohyama C
BJUI compass 3 ( 2 ) 154 - 161 2022.3
-
Characteristics of α2,3-sialyl N-glycosylated PSA as a biomarker for clinically significant prostate cancer in men with elevated PSA level.
Yoneyama T, Yamamoto H, Sutoh Yoneyama M, Tobisawa Y, Hatakeyama S, Narita T, Kodama H, Momota M, Ito H, Narita S, Tsushima F, Mitsuzuka K, Yoneyama T, Hashimoto Y, Duivenvoorden W, Pinthus JH, Kakeda S, Ito A, Tsuchiya N, Habuchi T, Ohyama C
The Prostate 81 ( 16 ) 1411 - 1427 2021.12
-
Utility of total cell-free DNA levels for surgical damage evaluation in patients with urological surgeries.
Konishi S, Narita T, Hatakeyama S, Yoneyama T, Yoneyama MS, Tobisawa Y, Noro D, Sato T, Togashi K, Okamoto T, Yamamoto H, Yoneyama T, Hashimoto Y, Ohyama C
Scientific reports 11 ( 1 ) 22103 2021.11
-
Comparison of pembrolizumab with conventional chemotherapy after first-line platinum-based chemotherapy for advanced urothelial carcinoma in real-world practice: A multicenter retrospective study.
Narita T, Hatakeyama S, Numakura K, Kobayashi M, Muto Y, Saito M, Narita S, Tanaka T, Noro D, Tokui N, Yoneyama T, Hashimoto Y, Habuchi T, Ohyama C
International journal of urology : official journal of the Japanese Urological Association 28 ( 9 ) 899 - 905 2021.9
-
The effect of frailty on the quality of life and lower urinary symptoms following robot-assisted radical prostatectomy: A longitudinal analysis (FRARP-QL Study).
Kyo Togashi, Shingo Hatakeyama, Yuta Kojima, Masaki Momota, Takuma Narita, Hiromichi Iwamura, Itsuto Hamano, Tomoko Hamaya, Naoki Fujita, Teppei Okamoto, Tohru Yoneyama, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama
Urologic oncology 39 ( 3 ) 192.e7 - 192.e14 2021.3
-
Impact of chronic kidney disease on oncological outcomes in patients with high-risk non-muscle-invasive bladder cancer who underwent adjuvant bacillus Calmette-Guérin therapy.
Naoki Fujita, Shingo Hatakeyama, Kazutaka Okita, Masaki Momota, Takuma Narita, Yuki Tobisawa, Tohru Yoneyama, Hayato Yamamoto, Atsushi Imai, Hiroyuki Ito, Takahiro Yoneyama, Yasuhiro Hashimoto, Kazuaki Yoshikawa, Chikara Ohyama
Urologic oncology 39 ( 3 ) 191.e9 - 191.e16 2021.3
-
A Longitudinal Study of Bidirectional Relationships between Sleep Disorder and Frequency of Nocturia: Results from the Iwaki Health Promotion Project.
Sakae Konishi, Shingo Hatakeyama, Atsushi Imai, Mika Kumagai, Teppei Okamoto, Kazutaka Okita, Itsuto Hamano, Takuma Narita, Yuta Kojima, Hiromichi Iwamura, Hayato Yamamoto, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama
Urologia internationalis 105 ( 3-4 ) 232 - 239 2021.3
-
Impact of chronic kidney disease on oncological outcomes in patients with high-risk non-muscle-invasive bladder cancer who underwent adjuvant bacillus Calmette-Guérin therapy.
Fujita N, Hatakeyama S, Okita K, Momota M, Narita T, Tobisawa Y, Yoneyama T, Yamamoto H, Imai A, Ito H, Yoneyama T, Hashimoto Y, Yoshikawa K, Ohyama C
Urologic oncology 39 ( 3 ) 191.e9 - 191.e16 2021.3
-
The effect of frailty on the quality of life and lower urinary symptoms following robot-assisted radical prostatectomy: A longitudinal analysis (FRARP-QL Study).
Togashi K, Hatakeyama S, Kojima Y, Momota M, Narita T, Iwamura H, Hamano I, Hamaya T, Fujita N, Okamoto T, Yoneyama T, Yamamoto H, Yoneyama T, Hashimoto Y, Ohyama C
Urologic oncology 39 ( 3 ) 192.e7 - 192.e14 2021.3
-
Relationship of frailty with treatment modality selection in patients with muscle-invasive bladder cancer (FRART-BC study).
Iwamura H, Hatakeyama S, Momota M, Kojima Y, Narita T, Okamoto T, Fujita N, Hamano I, Togashi K, Hamaya T, Yoneyama T, Yamamoto H, Yoneyama T, Hashimoto Y, Ohyama C
Translational andrology and urology 10 ( 3 ) 1143 - 1151 2021.3
-
Association between the baseline frailty and quality of life in patients with prostate cancer (FRAQ-PC study).
Tomoko Hamaya, Shingo Hatakeyama, Masaki Momota, Takuma Narita, Hiromichi Iwamura, Yuta Kojima, Itsuto Hamano, Naoki Fujita, Teppei Okamoto, Kyo Togashi, Tohru Yoneyama, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama
International journal of clinical oncology 26 ( 1 ) 199 - 206 2021.1
-
Therapeutic effects of the combined androgen blockade therapy versus luteinizing hormone-releasing hormone analog monotherapy in patients with hormone naïve metastatic prostate cancer: a multi-institutional comparative analysis.
Takuma Narita, Shingo Hatakeyama, Shintaro Narita, Masahiro Takahashi, Toshihiko Sakurai, Sadafumi Kawamura, Senji Hoshi, Jiro Shimoda, Toshiaki Kawaguchi, Shigeto Ishidoya, Koji Mitsuzuka, Yoichi Arai, Akihiro Ito, Norihiko Tsuchiya, Tomonori Habuchi, Chikara Ohyama
Translational andrology and urology 10 ( 1 ) 417 - 425 2021.1
-
Therapeutic effects of the combined androgen blockade therapy versus luteinizing hormone-releasing hormone analog monotherapy in patients with hormone naïve metastatic prostate cancer: a multi-institutional comparative analysis.
Narita T, Hatakeyama S, Narita S, Takahashi M, Sakurai T, Kawamura S, Hoshi S, Shimoda J, Kawaguchi T, Ishidoya S, Mitsuzuka K, Arai Y, Ito A, Tsuchiya N, Habuchi T, Ohyama C
Translational andrology and urology 10 ( 1 ) 417 - 425 2021.1
-
Association between the baseline frailty and quality of life in patients with prostate cancer (FRAQ-PC study).
Hamaya T, Hatakeyama S, Momota M, Narita T, Iwamura H, Kojima Y, Hamano I, Fujita N, Okamoto T, Togashi K, Yoneyama T, Yamamoto H, Yoneyama T, Hashimoto Y, Ohyama C
International journal of clinical oncology 26 ( 1 ) 199 - 206 2021.1
-
RARCと回腸を利用した尿路変向術
米山 高弘, 畠山 真吾, 橋本 安弘, 大山 力, 富樫 赳, 堀口 裕貴, 小玉 寛健, 成田 拓磨, 岩村 大径, 小島 由太, 岡本 哲平, 山本 勇人
Japanese Journal of Endourology 34 ( 1 ) 24 - 32 2021
-
A Longitudinal Study of Bidirectional Relationships between Sleep Disorder and Frequency of Nocturia: Results from the Iwaki Health Promotion Project.
Konishi S, Hatakeyama S, Imai A, Kumagai M, Okamoto T, Okita K, Hamano I, Narita T, Kojima Y, Iwamura H, Yamamoto H, Yoneyama T, Yoneyama T, Hashimoto Y, Ohyama C
Urologia internationalis 105 ( 3-4 ) 232 - 239 2021
-
Oncologic and patient-reported outcomes after robot-assisted radical prostatectomy in men aged ≥75 years.
Togashi K, Hatakeyama S, Okamoto T, Kojima Y, Iwamura H, Fujita N, Narita T, Hamano I, Hamaya T, Yoneyama T, Yamamoto H, Yoneyama T, Hashimoto Y, Ohyama C
Urologic oncology 2020.12
-
Impact of the Proportion of Biopsy Positive Core in Predicting Biochemical Recurrence in Patients with Pathological Pt2 and Negative Resection Margin Status after Radical Prostatectomy.
Oikawa M, Tanaka T, Narita T, Noro D, Iwamura H, Tobisawa Y, Yoneyama T, Kodama H, Hashimoto Y, Koie T, Ohyama C
Pathology oncology research : POR 26 ( 4 ) 2115 - 2121 2020.10
-
Safety and efficacy of intensive instillation of low-dose pirarubicin vs. bacillus Calmette-Guérin in patients with high-risk non-muscle-invasive bladder cancer.
Fujita N, Hatakeyama S, Momota M, Kido K, Narita T, Tobisawa Y, Yoneyama T, Yamamoto H, Imai A, Ito H, Yoneyama T, Hashimoto Y, Yoshikawa K, Ohyama C
Urologic oncology 38 ( 8 ) 684.e17 - 684.e24 2020.8
-
Castration-resistant prostate cancer without metastasis at presentation may achieve cancer-specific survival in patients who underwent prior radical prostatectomy.
Kodama H, Koie T, Oikawa M, Narita T, Tanaka T, Noro D, Iwamura H, Tobisawa Y, Yoneyama T, Hashimoto Y, Ohyama C
International urology and nephrology 52 ( 4 ) 671 - 679 2020.4
-
ハイリスク前立腺癌に対する術前内分泌化学療法後のロボット支援前立腺全摘術 (RARP) の治療成績
米山 高弘, 今井 篤, 畠山 真吾, 橋本 安弘, 大山 力, 濱谷 智子, 百田 匡毅, 濱野 逸人, 成田 拓磨, 岩村 大径, 小島 由太, 岡本 哲平, 山本 勇人
Japanese Journal of Endourology 33 ( 2 ) 325 - 329 2020
-
Clinical Characterization of Low Prostate-specific Antigen on Prognosis in Patients With Metastatic Castration-naive Prostate Cancer.
Kodama H, Hatakeyama S, Narita S, Takahashi M, Sakurai T, Kawamura S, Hoshi S, Ishida M, Kawaguchi T, Ishidoya S, Shimoda J, Narita T, Sato H, Mitsuzuka K, Tochigi T, Tsuchiya N, Arai Y, Habuchi T, Ohyama C
Clinical genitourinary cancer 17 ( 6 ) e1091 - e1098 2019.12
-
Evaluating the effects of switching from dutasteride to tadalafil in benign prostatic hyperplasia patients with lower urinary tract symptoms: A randomized, open-label, multicenter study.
Matsumoto T, Hatakeyama S, Narita T, Yoneyama T, Hashimoto Y, Ohyama C
International journal of urology : official journal of the Japanese Urological Association 26 ( 4 ) 522 - 523 2019.4
-
Neoadjuvant chemohormonal therapy followed by robot-assisted and minimum incision endoscopic radical prostatectomy in patients with high-risk prostate cancer: comparison of perioperative and oncological outcomes at single institution.
Fujita N, Koie T, Hashimoto Y, Narita T, Tobisawa Y, Tanaka T, Noro D, Oikawa M, Hagiwara K, Yoneyama T, Imai A, Yamamoto H, Hatakeyama S, Yoneyama T, Ohyama C
International urology and nephrology 50 ( 11 ) 1999 - 2005 2018.11
-
Significance of Serum N-glycan Profiling as a Diagnostic Biomarker in Urothelial Carcinoma.
Oikawa M, Hatakeyama S, Yoneyma T, Tobisawa Y, Narita T, Yamamoto H, Hashimoto Y, Koie T, Narita S, Sasaki A, Tsuchiya N, Habuchi T, Takahashi I, Nakaji S, Ohyama C
European urology focus 4 ( 3 ) 405 - 411 2018.4
-
Cost-effectiveness comparison between neoadjuvant chemohormonal therapy and extended pelvic lymph node dissection in high-risk prostate cancer patients treated with radical prostatectomy: a multi-institutional analysis.
Matsumoto T, Hatakeyama S, Ookubo T, Mitsuzuka K, Narita S, Inoue T, Yamashita S, Narita T, Koie T, Kawamura S, Tochigi T, Tsuchiya N, Habuchi T, Arai Y, Ohyama C
Medical oncology (Northwood, London, England) 34 ( 12 ) 190 2017.10
-
Preoperative chronic kidney disease predicts poor oncological outcomes after radical nephroureterectomy in patients with upper urinary tract urothelial carcinoma.
Kodama H, Hatakeyama S, Fujita N, Iwamura H, Anan G, Fukushi K, Narita T, Tanaka T, Kubota Y, Horiguchi H, Momota M, Kido K, Matsumoto T, Soma O, Hamano I, Yamamoto H, Tobisawa Y, Yoneyama T, Yoneyama T, Hashimoto Y, Koie T, Ito H, Yoshikawa K, Sasaki A, Kawaguchi T, Sato M, Ohyama C
Oncotarget 8 ( 47 ) 83183 - 83194 2017.10
-
Preoperative chronic kidney disease predicts poor oncological outcomes after radical cystectomy in patients with muscle-invasive bladder cancer.
Hamano I, Hatakeyama S, Iwamurau H, Fujita N, Fukushi K, Narita T, Hagiwara K, Kusaka A, Hosogoe S, Yamamoto H, Tobisawa Y, Yoneyama T, Yoneyama T, Hashimoto Y, Koie T, Ito H, Yoshikawa K, Kawaguchi T, Ohyama C
Oncotarget 8 ( 37 ) 61404 - 61414 2017.9
-
Risk-stratified surveillance and cost effectiveness of follow-up after radical cystectomy in patients with muscle-invasive bladder cancer.
Kusaka A, Hatakeyama S, Hosogoe S, Hamano I, Iwamura H, Fujita N, Fukushi K, Narita T, Hagiwara K, Yamamoto H, Tobisawa Y, Yoneyama T, Yoneyama T, Hashimoto Y, Koie T, Ito H, Yoshikawa K, Kawaguchi T, Ohyama C
Oncotarget 8 ( 39 ) 65492 - 65505 2017.9
-
Presence of transient hydronephrosis immediately after surgery has a limited influence on renal function 1 year after ileal neobladder construction.
Narita T, Hatakeyama S, Koie T, Hosogoe S, Matsumoto T, Soma O, Yamamoto H, Yoneyama T, Tobisawa Y, Yoneyama T, Hashimoto Y, Ohyama C
BMC urology 17 ( 1 ) 72 2017.8
-
Detecting asymptomatic recurrence after radical cystectomy contributes to better prognosis in patients with muscle-invasive bladder cancer.
Kusaka A, Hatakeyama S, Hosogoe S, Hamano I, Iwamura H, Fujita N, Fukushi K, Narita T, Yamamoto H, Tobisawa Y, Yoneyama T, Yoneyama T, Hashimoto Y, Koie T, Ito H, Yoshikawa K, Kawaguchi T, Ohyama C
Medical oncology (Northwood, London, England) 34 ( 5 ) 90 2017.5
-
Difference in toxicity reporting between patients and clinicians during systemic chemotherapy in patients with urothelial carcinoma.
Fukushi K, Narita T, Hatakeyama S, Yamamoto H, Tobisawa Y, Yoneyama T, Yoneyama T, Hashimoto Y, Koie T, Ohyama C
International journal of urology : official journal of the Japanese Urological Association 24 ( 5 ) 361 - 366 2017.5
-
Clinical relevance of aortic calcification in urolithiasis patients.
Tanaka T, Hatakeyama S, Yamamoto H, Narita T, Hamano I, Matsumoto T, Soma O, Tobisawa Y, Yoneyama T, Yoneyama T, Hashimoto Y, Koie T, Takahashi I, Nakaji S, Terayama Y, Funyu T, Ohyama C
BMC urology 17 ( 1 ) 25 2017.4
-
Clinical implications of serum N-glycan profiling as a diagnostic and prognostic biomarker in germ-cell tumors.
Narita T, Hatakeyama S, Yoneyama T, Narita S, Yamashita S, Mitsuzuka K, Sakurai T, Kawamura S, Tochigi T, Takahashi I, Nakaji S, Tobisawa Y, Yamamoto H, Koie T, Tsuchiya N, Habuchi T, Arai Y, Ohyama C
Cancer medicine 6 ( 4 ) 739 - 748 2017.4
-
Quality-of-life evaluation during platinum-based neoadjuvant chemotherapies for urothelial carcinoma.
Fukushi K, Narita T, Hatakeyama S, Yamamoto H, Soma O, Matsumoto T, Tobisawa Y, Yoneyama T, Imai A, Yoneyama T, Hashimoto Y, Koie T, Ohyama C
International journal of clinical oncology 22 ( 2 ) 366 - 372 2017.4
-
Clinical implications of serum N-glycan profiling as a diagnostic and prognostic biomarker in germ-cell tumors.
Takuma Narita, Shingo Hatakeyama, Tohru Yoneyama, Shintaro Narita, Shinichi Yamashita, Koji Mitsuzuka, Toshihiko Sakurai, Sadafumi Kawamura, Tatsuo Tochigi, Ippei Takahashi, Shigeyuki Nakaji, Yuki Tobisawa, Hayato Yamamoto, Takuya Koie, Norihiko Tsuchiya, Tomonori Habuchi, Yoichi Arai, Chikara Ohyama
Cancer medicine 2017.3
-
Difference in toxicity reporting between patients and clinicians during systemic chemotherapy in patients with urothelial carcinoma.
Ken Fukushi, Takuma Narita, Shingo Hatakeyama, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Chikara Ohyama
International journal of urology : official journal of the Japanese Urological Association 2017.3
-
Quality-of-life evaluation during platinum-based neoadjuvant chemotherapies for urothelial carcinoma.
Ken Fukushi, Takuma Narita, Shingo Hatakeyama, Hayato Yamamoto, Osamu Soma, Teppei Matsumoto, Yuki Tobisawa, Tohru Yoneyama, Atsushi Imai, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Chikara Ohyama
International journal of clinical oncology 22 ( 2 ) 366 - 372 2017.3
-
Aortic calcification burden predicts deterioration of renal function after radical nephrectomy.
Ken Fukushi, Shingo Hatakeyama, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Osamu Soma, Teppei Matsumoto, Itsuto Hamano, Takuma Narita, Atsushi Imai, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Yuriko Terayama, Tomihisa Funyu, Chikara Ohyama
BMC urology 17 ( 1 ) 13 - 13 2017.2
-
Aortic calcification burden predicts deterioration of renal function after radical nephrectomy.
Fukushi K, Hatakeyama S, Yamamoto H, Tobisawa Y, Yoneyama T, Soma O, Matsumoto T, Hamano I, Narita T, Imai A, Yoneyama T, Hashimoto Y, Koie T, Terayama Y, Funyu T, Ohyama C
BMC urology 17 ( 1 ) 13 2017.2
-
The impact of extended lymph node dissection versus neoadjuvant therapy with limited lymph node dissection on biochemical recurrence in high-risk prostate cancer patients treated with radical prostatectomy: a multi-institutional analysis.
Takuma Narita, Takuya Koie, Teppei Ookubo, Koji Mitsuzuka, Shintaro Narita, Hayato Yamamoto, Takamitsu Inoue, Shingo Hatakeyama, Sadafumi Kawamura, Tatsuo Tochigi, Tomonori Habuchi, Yoichi Arai, Chikara Ohyama
Medical oncology (Northwood, London, England) 34 ( 1 ) 1 - 1 2017.1
-
The impact of extended lymph node dissection versus neoadjuvant therapy with limited lymph node dissection on biochemical recurrence in high-risk prostate cancer patients treated with radical prostatectomy: a multi-institutional analysis.
Narita T, Koie T, Ookubo T, Mitsuzuka K, Narita S, Yamamoto H, Inoue T, Hatakeyama S, Kawamura S, Tochigi T, Habuchi T, Arai Y, Ohyama C
Medical oncology (Northwood, London, England) 34 ( 1 ) 1 2017.1
-
The influence of serum uric acid on renal function in patients with calcium or uric acid stone: A population-based analysis.
Tanaka Y, Hatakeyama S, Tanaka T, Yamamoto H, Narita T, Hamano I, Matsumoto T, Soma O, Okamoto T, Tobisawa Y, Yoneyama T, Yoneyama T, Hashimoto Y, Koie T, Takahashi I, Nakaji S, Terayama Y, Funyu T, Ohyama C
PloS one 12 ( 7 ) e0182136 2017
-
Correction: Renal Function Outcomes and Risk Factors for Risk Factors for Stage 3B Chronic Kidney Disease after Urinary Diversion in Patients with Muscle Invasive Bladder Cancer.
Shingo Hatakeyama, Takuya Koie, Takuma Narita, Shogo Hosogoe, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama
PloS one 11 ( 3 ) e0151742 - e0151742 2016
-
Correction: Renal Function Outcomes and Risk Factors for Risk Factors for Stage 3B Chronic Kidney Disease after Urinary Diversion in Patients with Muscle Invasive Bladder Cancer.
Hatakeyama S, Koie T, Narita T, Hosogoe S, Yamamoto H, Tobisawa Y, Yoneyama T, Yoneyama T, Hashimoto Y, Ohyama C
PloS one 11 ( 3 ) e0151742 2016
-
Renal Function Outcomes and Risk Factors for Stage 3B Chronic Kidney Disease after Urinary Diversion in Patients with Muscle Invasive Bladder Cancer [corrected].
Hatakeyama S, Koie T, Narita T, Hosogoe S, Yamamoto H, Tobisawa Y, Yoneyama T, Yoneyama T, Hashimoto Y, Ohyama C
PloS one 11 ( 2 ) e0149544 2016
-
The protective roles of GLP-1R signaling in diabetic nephropathy: possible mechanism and therapeutic potential.
Fujita H, Morii T, Fujishima H, Sato T, Shimizu T, Hosoba M, Tsukiyama K, Narita T, Takahashi T, Drucker DJ, Seino Y, Yamada Y
Kidney international 85 ( 3 ) 579 - 89 2014.3
-
[Capillary hemangioma in renal hilum; a case report].
Oikawa M, Hatakeyama S, Hamano I, Tanaka T, Tanaka Y, Narita T, Noro D, Hagiwara K, Ohyama C
Hinyokika kiyo. Acta urologica Japonica 60 ( 1 ) 33 - 7 2014.1
-
Prognostic benefit of surgical management in renal cell carcinoma patients with thrombus extending to the renal vein and inferior vena cava: 17-year experience at a single center.
Hatakeyama S, Yoneyama T, Hamano I, Murasawa H, Narita T, Oikawa M, Hagiwara K, Noro D, Tanaka T, Tanaka Y, Hashimoto Y, Koie T, Ohyama C
BMC urology 13 47 2013.10
-
Switching hemodialysis patients from sevelamer hydrochloride to bixalomer: a single-center, non-randomized analysis of efficacy and effects on gastrointestinal symptoms and metabolic acidosis.
Hatakeyama S, Murasawa H, Narita T, Oikawa M, Fujita N, Iwamura H, Mikami J, Kojima Y, Sato T, Fukushi K, Ishibashi Y, Hashimoto Y, Koie T, Saitoh H, Funyu T, Ohyama C
BMC nephrology 14 222 2013.10
-
Prognosis of elderly Japanese patients aged ≥80 years undergoing hemodialysis.
Hatakeyama S, Murasawa H, Hamano I, Kusaka A, Narita T, Oikawa M, Noro D, Hagiwara K, Ishimura H, Yoneyama T, Hashimoto Y, Koie T, Saitoh H, Funyu T, Ohyama C
TheScientificWorldJournal 2013 693514 2013